The Manufacturers Life Insurance Company Takes Position in Teleflex Incorporated $TFX

The Manufacturers Life Insurance Company acquired a new position in shares of Teleflex Incorporated (NYSE:TFX) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 216,740 shares of the medical technology company’s stock, valued at approximately $27,474,000.

A number of other institutional investors and hedge funds also recently modified their holdings of TFX. Kelleher Financial Advisors purchased a new position in Teleflex in the 2nd quarter worth about $25,000. Banque Cantonale Vaudoise lifted its stake in Teleflex by 82.5% during the fourth quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock valued at $31,000 after buying an additional 113 shares in the last quarter. UMB Bank n.a. boosted its holdings in shares of Teleflex by 57.1% in the fourth quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock worth $38,000 after buying an additional 113 shares during the period. Allworth Financial LP acquired a new position in shares of Teleflex in the second quarter worth about $44,000. Finally, Kestra Advisory Services LLC acquired a new stake in shares of Teleflex during the fourth quarter valued at approximately $45,000. 95.62% of the stock is owned by institutional investors and hedge funds.

Teleflex Stock Down 0.8%

TFX opened at $137.65 on Friday. Teleflex Incorporated has a fifty-two week low of $100.18 and a fifty-two week high of $145.00. The business has a 50-day moving average of $133.60 and a 200-day moving average of $125.81. The company has a debt-to-equity ratio of 0.94, a current ratio of 2.60 and a quick ratio of 2.12. The company has a market capitalization of $5.83 billion, a PE ratio of -5.91, a price-to-earnings-growth ratio of 0.92 and a beta of 0.81.

Teleflex (NYSE:TFX) last issued its quarterly earnings data on Thursday, August 6th. The medical technology company reported $1.76 earnings per share for the quarter, beating the consensus estimate of $1.28 by $0.48. The firm had revenue of $570.33 million for the quarter, compared to analyst estimates of $559.59 million. Teleflex had a negative net margin of 39.67% and a positive return on equity of 11.93%. The company’s revenue for the quarter was up 28.9% on a year-over-year basis. During the same quarter last year, the firm earned $3.73 earnings per share. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. Equities research analysts forecast that Teleflex Incorporated will post 7.26 EPS for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Friday, August 14th will be paid a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. The ex-dividend date of this dividend is Friday, August 14th. Teleflex’s payout ratio is presently -5.84%.

Wall Street Analyst Weigh In

Several research firms have weighed in on TFX. Needham & Company LLC lifted their price objective on shares of Teleflex from $159.00 to $170.00 and gave the stock a “buy” rating in a research report on Tuesday. Royal Bank Of Canada upgraded Teleflex from a “sector perform” rating to an “outperform” rating and lifted their price target for the company from $135.00 to $155.00 in a report on Friday, May 8th. UBS Group increased their price objective on Teleflex from $145.00 to $158.00 and gave the stock a “neutral” rating in a research note on Tuesday, August 11th. Truist Financial raised their price objective on Teleflex from $143.00 to $150.00 and gave the stock a “hold” rating in a research report on Monday, August 10th. Finally, Raymond James Financial reaffirmed an “outperform” rating and set a $150.00 target price on shares of Teleflex in a research note on Friday, May 8th. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Teleflex has a consensus rating of “Hold” and an average target price of $152.90.

Teleflex Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.